MEHNAZ KAMAL Ph.D. (Integral University); PGDIPR (Indira Gandhi National Open University); M. Pharm. (Jamia Hamdard Faculty of Pharmacy); B. Pharm. (Manipal University)
PROFESSOR, Prince Sattam bin Abdulaziz University College of Pharmacy, Al-Kharj, RIYADH · Saudi Arabia
Editorial leadership for Journal of Advanced Pharmaceutical Science And Technology ISSN 2328-0182
Research interests
- Synthesis
- Anticonvulsant
- Hepatoprotective
- Antiulcer
- Drug Discovery
- Adaptogenic
Biography
Dr. Mehnaz Kamal is a Professor at the College of Pharmacy, Prince Sattam bin Abdulaziz University, Al-Kharj, Riyadh, Saudi Arabia, with research expertise spanning synthesis, anticonvulsant, hepatoprotective, and antiulcer drug discovery. She has published over 50 indexed articles, with her most-cited work, "Citrus Essential Oils in Aromatherapy: Therapeutic Effects and Mechanisms" (2022), receiving 123 citations. Dr. Kamal serves on the editorial boards of the Edorium Journal of Pharmacology, Pelagia Research Library, and the Journal of Advanced Pharmaceutical Science and Technology. She is a life member of the Association of Pharmaceutical Teachers of India (APTI) and the Society of Pharmaceutical Education and Research (SPER), reflecting her sustained commitment to pharmaceutical education and research advancement.
Selected publications
- Citrus Essential Oils in Aromatherapy: Therapeutic Effects and Mechanisms 2022 cited 123×
- Nanodelivery of Dietary Polyphenols for Therapeutic Applications 2022 cited 68×
- The Therapeutic and Prophylactic Potential of Quercetin against COVID-19: An Outlook on the Clinical Studies, Inventive Compositions, and Patent Literature 2022 cited 63×
- A Glance at the Development and Patent Literature of Tecovirimat: The First-in-Class Therapy for Emerging Monkeypox Outbreak 2022 cited 48×
- Discovery, Development, Inventions and Patent Review of Fexinidazole: The First All-Oral Therapy for Human African Trypanosomiasis 2022 cited 41×
- Oral Brincidofovir Therapy for Monkeypox Outbreak: A Focused Review on the Therapeutic Potential, Clinical Studies, Patent Literature, and Prospects 2023 cited 33×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JAPST for your work?
This journal is guided by MEHNAZ KAMAL (PROFESSOR, Prince Sattam bin Abdulaziz University College of Pharmacy, Al-Kharj, RIYADH) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.